Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Niche Cancers 2001: Acute Myeloid Leukemia Datamonitor, July 2001   Description     Table of Contents        Enquire before Buying    Send to a Friend   Disease Overview - incidence, classification and diagnosis * Market Analysis - global sales and profiles of individual drugs currently on the market * Unmet Needs - unmet needs associated with current drug therapies, the characteristics needed to offer superior treatment and the projected direction of future R&D activity * Pipeline * Analysis - R&D pipeline, with profiles of the key drugs in development * Market * Forecasts - future trends in the incidence of each cancer type and drug sales forecasts to 2007 Customers who bought this item also bought Acute Myeloid Leukemia: Cytarabine Here to Stay Drugs of Tomorrow: Leukemia - Chemopotentiators Will Drive Growth in the Acute Leukemia Markets Chronic Myeloid Leukemia - Gleevec resistance is opening a market for synergistic use Acute Leukemias - Persistent Unmet Needs Confer Significant Commercial Opportunity Niche Cancers 2001: Glioblastoma Niche Cancers 2001: Sarcoma Niche Cancers 2001: Head and Neck Cancer Niche Cancers 2001: Melanoma

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster